Showing results (1-10 of 188) with videos related to
Sort By:
Pageof 19
Thorax|April 8, 2006
Extracellular thioredoxin levels are increased in patients with acute lung injuryM E Callister, A Burke-Gaffney, G J Quinlan, et al.Scandinavian Journal of Infectious Diseases|December 1, 2001
Descending necrotizing mediastinitis caused by group A streptococcus (serotype M1T1)M E Callister, R A WallBritish Journal of Pharmacology|July 1, 2008
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cellsM E Callister, L Pinhu, M C Catley, et al.Alimentary Pharmacology & Therapeutics|November 9, 2002
Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressureT W EvansCritical Care Medicine|June 11, 1999
Molecular biology for the critical care physician. Part II: where are we now?G Santis, T W EvansCritical Care Medicine|May 13, 1999
Molecular biology for the critical care physician part I: terminology and technologyG Santis, T W EvansLancet (London, England)|March 26, 1994
Allocation of resources in intensive care: a transatlantic perspectiveM Osborne, T W EvansThe European Respiratory Journal|March 1, 1997
Nitric oxide, the biological mediator of the decade: fact or fiction?S Singh, T W EvansAmerican Journal of Respiratory and Critical Care Medicine|March 28, 1998
Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndromeS J Brett, T W EvansChest|February 1, 1994
The effect of exogenous surfactant therapy on lung function following cardiopulmonary bypassP D Macnaughton, T W EvansPageof 19